Dissemination and Implementation Research in Communication Disorders Conference (U13 Clinical Trial Not Allowed)
ID: 355688Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355688

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-DC-24-009.html
Timeline
    Description

    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), invites applications for funding to organize and execute an annual conference focused on dissemination and implementation research in communication disorders. The primary objectives of this U13 cooperative agreement grant are to enhance research skills related to hearing, balance, taste, smell, voice, speech, and language, while addressing critical gaps in dissemination and implementation science and promoting inclusivity among participants. Funding of up to $100,000 is available for a single conference, with applications due by November 25, 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-DC-24-009.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-DC-24-009-Full-Announcement.html
    RFA-DC-24-009.html
    The National Institutes of Health (NIH), specifically the National Institute on Deafness and Other Communication Disorders (NIDCD), invites applications for funding to organize and execute an annual conference aimed at disseminating and implementing research skills in communication disorders. This initiative, identified as a U13 cooperative agreement grant, intends to enhance attendees’ abilities to conduct effective dissemination and implementation (D&I) research related to hearing, balance, taste, smell, voice, speech, and language. The conference should address critical D&I science gaps, foster collaborative research, and ensure inclusivity across all NIDCD mission areas. Key objectives include integrating core D&I research elements, developing strategies to increase evidence-based practices adoption, and enhancing diversity among participants. Funding of up to $100,000 is available for a single conference, and applications must be submitted by specific deadlines to meet NIH guidelines. An emphasis on creating a safe, respectful, and accessible environment for all attendees is mandated, aligning with NIH’s commitment to diversity and preventing harassment in scientific forums. The document outlines comprehensive application requirements, review criteria, and the necessity for a robust steering committee to oversee the conference logistics and evaluation.
    Similar Opportunities
    Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), has announced a funding opportunity titled "Early-Stage Dissemination and Implementation Research in Communication Disorders" under the R21 grant mechanism. This initiative aims to support early-stage research projects that enhance the dissemination and implementation of evidence-based innovations (EBIs) in areas such as hearing, speech, balance, taste, and language, with a focus on addressing barriers to adoption in clinical settings. The funding opportunity will provide approximately $1 million, with individual project budgets capped at $275,000 over a two-year period, and applications are due by October 12, 2024. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), is offering a funding opportunity titled "NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)." This initiative aims to support cooperative agreements for clinical trials that require FDA oversight, are intended to establish efficacy, or present higher risks to participants, with a budget exceeding $700,000. The funding is crucial for advancing clinical practices in treating communication disorders, emphasizing the inclusion of diverse populations in recruitment and retention strategies. Interested applicants, including various educational and nonprofit organizations, must submit their applications by January 27, 2024, and can find more information at NIH Grants.
    NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), is offering Clinical Research Center Grants (P50) aimed at advancing the diagnosis, prevention, treatment, and amelioration of human communication disorders. The grants support interdisciplinary research teams focusing on various communication issues, including those related to hearing, balance, smell, taste, voice, speech, and language, with applications permitted for low-risk clinical trials, although they are not mandatory. Eligible applicants include a wide range of institutions such as public and private higher education institutions, nonprofits, and local and state governments, with budgets capped at $1.5 million per year for a maximum project period of five years. Interested parties should submit their applications by October 9, 2024, and can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), has announced a funding opportunity for low-risk clinical trials in communication disorders under Funding Opportunity Number PAR-24-051. This initiative aims to support investigator-initiated projects that develop effective interventions in areas such as hearing, speech, and language, specifically targeting low-risk clinical trials that do not require FDA oversight and adhere to budget limits of under $500,000 in direct costs per year. The funding is particularly significant for enhancing research in communication disorders, ultimately improving public health outcomes through scientifically validated interventions. Interested applicants can submit proposals starting January 5, 2024, with the opportunity closing on January 8, 2028; for further inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through its National Institute on Deafness and Other Communication Disorders (NIDCD), has announced a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)." This grant aims to stimulate innovative research addressing critical issues related to communication disorders—such as hearing, balance, taste, smell, voice, speech, and language—specifically for individuals living with HIV/AIDS. The initiative encourages multidisciplinary collaborations and supports low-risk clinical trials that do not require FDA oversight, with a total funding limit of $275,000 for two-year projects, and no more than $200,000 in any single year. Interested applicants, including various academic institutions and nonprofits, must submit their proposals by January 7, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the NIH Research Conference Grant (R13) to support high-quality scientific conferences that align with public health and the scientific missions of participating Institutes and Centers. This initiative encourages diverse participation and requires applicants to submit a detailed diversity plan, conference objectives, and logistical arrangements, while ensuring that costs align with actual project needs. The funding is crucial for fostering inclusive environments at scientific gatherings, with applications evaluated based on significance, innovation, approach, and diversity. Interested applicants can find more information and guidelines at the NIH website, with the application submission period opening on March 12, 2024, and closing on January 8, 2027. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    NIOSH Support for Conferences and Scientific Meetings (U13 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute for Occupational Safety and Health (NIOSH), is offering funding opportunities for conferences and scientific meetings aimed at promoting occupational safety and health. The initiative seeks to support high-quality gatherings that advance research and address priority areas in the field of occupational health, with applications invited under the U13 funding mechanism, which facilitates cooperative agreements involving significant federal staff engagement. Up to four awards may be granted annually, with a total funding allocation of $600,000 over five years, allowing for individual conference funding of up to $30,000, extendable to $75,000 with prior approval. Interested applicants, including educational institutions and nonprofits, must ensure their proposals align with NIOSH’s strategic goals and address health disparities, with applications due by December 14, 2025. For further details, applicants can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV or visit the funding announcement at http://grants.nih.gov/grants/guide/pa-files/PAR-21-193.html.
    Research Experiences to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Experiences to Enhance Clinician-Scientists' Participation in NIDCD’s Research" under the R25 Clinical Trial Not Allowed grant program. This initiative aims to recruit and prepare clinician researchers, particularly from underrepresented groups, by providing hands-on research experiences and developing scientific skills in areas related to hearing, balance, taste, smell, voice, speech, and language research. The program emphasizes the importance of diversity in participant recruitment and requires an effective evaluation and dissemination plan, with a maximum funding amount of $250,000 per year for projects lasting up to five years. Interested applicants must submit their proposals by October 1, 2024, and can reach out to the NIH OER Webmaster at grantsinfo@nih.gov for further assistance.
    NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)" aimed at supporting independent research projects that enhance workforce diversity in health-related sciences. This initiative specifically targets Early Stage and New Investigators from diverse backgrounds, particularly those underrepresented in biomedical, clinical, and social sciences, and does not require preliminary data for application submissions. The NIH intends to commit $2.7 million to this program, with individual awards capped at $500,000 per year for a maximum duration of five years. Interested applicants can find more information and application details at the NIH grants website, and they must submit their applications by February 6, 2025, with the application submission opening on January 28, 2024.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)" aimed at stimulating research related to communication disorders associated with HIV/AIDS. This initiative encourages innovative, hypothesis-driven research that addresses high-priority areas such as hearing, speech, and language, with a focus on low-risk clinical trials that do not require FDA oversight. Eligible applicants include a wide range of organizations, such as higher education institutions and community-based organizations, with funding available up to $499,999 per year for projects lasting up to five years. Interested parties should submit their applications by January 7, 2026, and can find more information by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the announcement page at https://grants.nih.gov/grants/guide/pa-files/PAR-23-099.html.